Article
Mutant p53 expression: a marker of diminished survival in well-differentiated soft tissue sarcoma.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Aug 1996
Hieken T J, Das Gupta T K
Abstract excerpt
The aim of this study was to assess the translational value of the quantitative assay of mutant p53 protein expression as both a prognostic indicator and a tool to determine appropriate therapy in a group of relatively innocuous and morphologically similar soft tissue sarcomas (STSs). Using a quantitative ELISA, we analyzed mutant p53 protein expression in 47 well-differentiated (grade I) STSs from patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
